The estimated Net Worth of Raymond Fujikawa is at least $2.46 Million dollars as of 20 June 2018. Raymond Fujikawa owns over 32,243 units of Orthofix Medical Inc stock worth over $223,747 and over the last 8 years Raymond sold OFIX stock worth over $2,240,841.
Raymond has made over 2 trades of the Orthofix Medical Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Raymond sold 32,243 units of OFIX stock worth $1,941,351 on 20 June 2018.
The largest trade Raymond's ever made was selling 32,243 units of Orthofix Medical Inc stock on 20 June 2018 worth over $1,941,351. On average, Raymond trades about 7,721 units every 63 days since 2016. As of 20 June 2018 Raymond still owns at least 12,859 units of Orthofix Medical Inc stock.
You can see the complete history of Raymond Fujikawa stock trades at the bottom of the page.
Raymond's mailing address filed with the SEC is 3451 PLANO PKWY, , LEWISVILLE, TX, 75056.
Over the last 22 years, insiders at Orthofix Medical Inc have traded over $19,062,472 worth of Orthofix Medical Inc stock and bought 182,076 units worth $5,806,101 . The most active insiders traders include Stuart Essig, Charles R. Kummeth, and Alexis V Lukianov. On average, Orthofix Medical Inc executives and independent directors trade stock every 53 days with the average trade being worth of $179,237. The most recent stock trade was executed by Kevin J. Kenny on 8 January 2024, trading 5,959 units of OFIX stock currently worth $103,687.
orthofix international began in a small farmhouse in verona italy in 1980 when orthopedic researcher giovanni de bastiani recognized the bone’s natural repair capability, a concept he called “dynamization” and with that in mind, he created the first external fixation device. today, orthofix has grown to more than 900 employees with locations in the u.s., italy, germany, france, the uk, brazil, australia and puerto rico. our products help patients in 70 countries around the world. the company is comprised of four strategic business units; biostim, biologics, extremity fixation and spine fixation. our products are widely distributed via the company's sales representatives, distributors and subsidiaries. at orthofix we are committed to clinical research and driven by new product introductions. we are proud of our strong partnerships with organizations such as the texas scottish rite hospital for children in dallas and the musculoskeletal transplant foundation. we take pride in developing
Orthofix Medical Inc executives and other stock owners filed with the SEC include: